These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 17460590

  • 21. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
    Wykrota H, Gierek-Łapińska A.
    Klin Oczna; 2002; 104(3-4):239-43. PubMed ID: 12608309
    [Abstract] [Full Text] [Related]

  • 22. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
    Voelker M, Gelisken F, Ziemssen F, Wachtlin J, Grisanti S.
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
    [Abstract] [Full Text] [Related]

  • 23. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, Wong TH.
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [Abstract] [Full Text] [Related]

  • 24. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM, Lai S, Markey CM.
    Clin Exp Ophthalmol; 2007 Aug; 35(1):24-31. PubMed ID: 17300567
    [Abstract] [Full Text] [Related]

  • 25. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH, Mittra RA.
    Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
    [Abstract] [Full Text] [Related]

  • 26. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
    Hamon F, Goeminne P.
    Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
    [Abstract] [Full Text] [Related]

  • 27. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [Abstract] [Full Text] [Related]

  • 28. Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
    Nicolò M, Ghiglione D, Lai S, Nasciuti F, Cicinelli S, Calabria G.
    Retina; 2006 Jan; 26(1):58-64. PubMed ID: 16395140
    [Abstract] [Full Text] [Related]

  • 29. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Ach T, Hoeh AE, Ruppenstein M, Kretz FT, Dithmar S.
    Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
    [Abstract] [Full Text] [Related]

  • 30. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.
    Ruiz-Moreno JM, Montero JA, Barile S, Zarbin MA.
    Retina; 2006 Oct; 26(6):602-12. PubMed ID: 16829800
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Verteporfin therapy in occult with no classic CNV due to AMD: results of the Photodynamic Therapy in Occult-Only Lesions study.
    Soubrane G, Harding SP, Wolf S, Weichselberger A.
    Eye (Lond); 2009 Apr; 23(4):791-800. PubMed ID: 18583995
    [Abstract] [Full Text] [Related]

  • 33. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.
    Gelisken F, Inhoffen W, Partsch M, Schneider U, Kreissig I.
    Am J Ophthalmol; 2001 Apr; 131(4):518-20. PubMed ID: 11292425
    [Abstract] [Full Text] [Related]

  • 34. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
    Ladd BS, Solomon SD, Bressler NM, Bressler SB.
    Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
    [Abstract] [Full Text] [Related]

  • 35. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
    Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC, Visudyne in Minimally Classic Choroidal Neovascularization Study Group.
    Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Photodynamic therapy with verteporfin in Belgian patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Mori R, Kelkar A, De Laey JJ.
    Bull Soc Belge Ophtalmol; 2006 Apr; (299):57-64. PubMed ID: 16681088
    [Abstract] [Full Text] [Related]

  • 38. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX, Ge J, Yan M, Jin CJ, Zhang MX, Dong FT, Lu F, Zhang CF, Zhao JL.
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.